LL-37 is a 37-amino-acid cathelicidin peptide — the only member of the cathelicidin family produced by humans. It is derived from the precursor protein hCAP18 (human cationic antimicrobial protein 18) through enzymatic cleavage by serine proteases, primarily in neutrophils, macrophages, and epithelial cells. LL-37 is produced at sites of infection and inflammation, at mucosal surfaces including the gut, lungs, and skin, and in response to immune activation. Its name reflects its structure: it begins with two leucine residues and contains 37 amino acids in total. Despite its relatively small size, LL-37 is one of the most multifunctional peptides in human innate immunity.
LL-37's antimicrobial mechanism is direct and powerful. Unlike antibodies that flag pathogens for destruction by other immune cells, LL-37 disrupts microbial cell membranes directly. Its cationic (positively charged) structure is attracted to the negatively charged membranes of bacteria, fungi, and enveloped viruses. Once it binds, it inserts itself into the membrane and disrupts its integrity — effectively punching holes in the pathogen's outer shell. This mechanism makes LL-37 broadly active against a wide range of microorganisms. Because it targets the physical structure of microbial membranes rather than specific metabolic pathways, it is effective against many organisms that have developed resistance to conventional approaches.
Beyond its direct antimicrobial function, LL-37 is a potent immune modulator. It activates and recruits innate immune cells, promotes wound healing through keratinocyte migration and proliferation, modulates inflammatory signaling, supports angiogenesis, and plays a significant role in skin barrier function. LL-37 expression is naturally suppressed by various factors including vitamin D deficiency, chronic stress, and certain health conditions. When LL-37 levels are insufficient, both the antimicrobial defense of mucosal surfaces and the inflammatory regulation of skin and gut tissue can be compromised.
We provide LL-37 as a prescription-compounded subcutaneous injection. The peptide absorbs into systemic circulation where it interacts with innate immune cells, mucosal surfaces, and epithelial tissue throughout the body. Most patients self-administer at home after comprehensive training from our licensed RN staff. Your physician determines the dosing frequency and protocol based on your specific immune defense and wellness goals.
LL-37's immune defense and antimicrobial effects begin through its interaction with immune cell receptors and direct action on microbial membranes at sites where it concentrates. The peptide also activates signaling pathways involved in wound healing, keratinocyte function, and mucosal immune regulation. Consistent dosing maintains LL-37 availability in the systemic and mucosal immune environments where it provides its broadest immune support.
Each treatment protocol is customized based on your specific immune defense needs, health history, and wellness goals. Our physicians evaluate your complete immune and skin wellness profile before prescribing. You receive a personalized physician-supervised protocol designed around your innate immune support needs — not a generic immune wellness approach.
Choosing where to receive LL-37 therapy matters for quality, safety, and clinical support. Here is what sets InjectCo apart from other providers across Texas.
LL-37 therapy offers targeted support for innate immune defense, skin health, and mucosal immune function. Here is what patients commonly experience after consistent LL-37 therapy.
LL-37 is a frontline component of your innate immune system's rapid response capability. Supporting healthy LL-37 levels may enhance the body's first-line defense at mucosal surfaces and sites of potential pathogen exposure.
Many patients use LL-37 therapy to support immune resilience — particularly those who feel their innate immune response has been compromised by chronic stress, aging, or other factors that suppress natural LL-37 production.
A robust innate immune response is the foundation of overall immune health. LL-37 supports the most immediate layer of immune defense that your body deploys before the adaptive immune system responds.
LL-37's direct membrane-disrupting antimicrobial action makes it broadly active against bacteria, fungi, and enveloped viruses. Supporting LL-37 levels maintains this direct-action antimicrobial capability throughout mucosal surfaces and skin.
Because LL-37 targets microbial membrane structure rather than specific metabolic pathways, it retains activity against many microorganisms regardless of their resistance profiles to conventional approaches.
Maintaining healthy LL-37 levels at mucosal surfaces — including the gut, respiratory tract, and skin — supports the antimicrobial defense that protects these vulnerable interfaces between your body and the external environment.
LL-37 plays a central role in skin immune defense, wound healing, and barrier maintenance. Keratinocytes — the primary cells of the outer skin layer — both produce and respond to LL-37, making it integral to skin health.
Supporting healthy LL-37 levels may contribute to improved skin barrier function, enhanced wound healing response, and better skin immune regulation. Many patients report improvements in skin health and appearance after consistent LL-37 therapy.
The connection between LL-37 and skin health extends beyond antimicrobial defense to include its roles in promoting keratinocyte migration for wound closure, supporting angiogenesis for tissue repair, and modulating skin inflammatory responses.
Mucosal surfaces — including the gut lining, respiratory tract, and urogenital tract — are the largest immune interface in your body. LL-37 is produced at these surfaces to maintain both antimicrobial defense and immune regulation.
Supporting healthy LL-37 levels at mucosal surfaces may help maintain the immune balance these critical interfaces require — protecting against pathogens while avoiding excessive inflammatory responses that damage the mucosal tissue itself.
Gut mucosal immune function connects directly to systemic immune status. Supporting LL-37 at this level has implications for overall immune health and inflammatory regulation throughout the body.
Beyond antimicrobial defense, LL-37 plays active roles in tissue repair — promoting keratinocyte migration, supporting new blood vessel formation, and modulating the inflammatory environment of healing tissue.
Supporting healthy LL-37 levels may contribute to more efficient wound healing and tissue repair responses. Many patients who use LL-37 for immune defense also report ancillary improvements in skin repair and tissue recovery.
LL-37's wound healing properties are one of the most actively researched aspects of this peptide. The same properties that make it relevant for immune defense also make it a meaningful tool for supporting the body's natural tissue repair capabilities.
Individual results vary. LL-37 is a compounded prescription therapy not intended to treat, cure, or prevent any disease.
We have streamlined LL-37 therapy to make it accessible and effective. Here is your step-by-step journey at InjectCo from consultation through treatment.
Schedule your complimentary LL-37 consultation online or by phone today. We offer same-week availability at all 8 Texas locations for convenience.
A physician reviews your complete health history, immune wellness profile, and specific goals for innate immune and skin health support. We discuss your interest in LL-37 and why it may align with your needs.
This consultation is required before prescribing any LL-37 therapy here. It ensures LL-37 is appropriate for your individual health status and immune wellness goals.
Based on your consultation, we prescribe a specific LL-37 treatment protocol including dosage and frequency. You receive clear pricing upfront before any commitments.
We explain exactly what LL-37 may support for your specific immune defense and wellness goals. There are no surprises or hidden fees discovered later unexpectedly.
You decide if LL-37 therapy fits your wellness goals and budget. Our team educates and guides — we never pressure you into treatments.
Your LL-37 prescription is filled by our pharmaceutical compounding partner. Licensed RN injectors train you on proper subcutaneous self-administration techniques thoroughly.
Most patients self-inject subcutaneously at home on their prescribed schedule. Our staff demonstrates proper injection methods, storage requirements, and disposal procedures clearly.
We ensure you understand how to use LL-37 safely and effectively. Proper technique and consistent dosing support the best possible innate immune support outcomes from your therapy.
Your LL-37 protocol evolves based on your immune wellness response over time. We schedule follow-up consultations to assess progress and adjust prescriptions as needed.
Our physicians modify dosing and frequency based on the immune wellness improvements you are experiencing. You are never locked into a protocol that is not working well for you.
Questions between appointments about your LL-37 therapy? Our medical team is available via phone to address concerns promptly.
LL-37 therapy supports various innate immune defense and skin wellness goals for many different people. Many incorporate it into comprehensive immune health and longevity optimization protocols.
You might consider LL-37 therapy if you want to:
The best candidates are people seeking to strengthen their innate immune defense, support skin immune health, or address mucosal immune function as part of a comprehensive wellness approach. Our physicians evaluate your health history to determine appropriateness specifically for you.
LL-37 therapy particularly benefits people whose natural cathelicidin levels may be suppressed by chronic stress, aging, vitamin D insufficiency, or other factors — and who want to support this critical first-line immune defense system through a targeted peptide approach.
Not every patient is a candidate for LL-37 therapy here. Certain health conditions, immune diagnoses, or medications may require alternative approaches or represent contraindications.
Your consultation reveals whether LL-37 aligns with your wellness goals. Our physicians provide honest recommendations based on your individual health today.
Your prescription is filled within 7 to 10 days of your consultation. We contact you when your LL-37 formulation is ready for pickup.
Pick up at the location most convenient for you. Our licensed RN staff provides detailed injection training and answers all questions at pickup.
Store your LL-37 refrigerated as directed to maintain potency. Most formulations remain stable for 30 days when properly stored away from light and heat.
Inject LL-37 subcutaneously as prescribed — frequency varies by protocol from daily to several times per week depending on your physician's recommendation and immune wellness goals.
Administer in abdominal tissue for consistent absorption. Rotate injection sites slightly to prevent tissue irritation from repeated injections in the same area.
Consistent dosing maintains LL-37 availability throughout the immune systems it supports. Track any changes in immune resilience, skin health, and overall wellness as you progress through therapy.
Innate immune support benefits from LL-37 therapy often develop gradually over weeks of consistent use. Improvements in immune resilience, skin health, and mucosal wellness are the primary indicators to track.
Note any changes in these areas and share them with your physician at follow-up. These observations help optimize your protocol and ensure appropriate dosing for your immune wellness goals.
InjectCo believes in transparent pricing for all prescription peptide therapies always. Here is what LL-37 therapy costs at our Texas locations.
Pricing varies based on LL-37 dosage and protocol frequency prescribed for you. Your physician determines appropriate dosing during your initial consultation.
Many patients combine LL-37 with VIP for comprehensive innate and regulatory immune support, or with Glutathione for combined immune defense and antioxidant wellness. Your physician determines safe combinations for you.
We accept all major credit cards, HSA, and FSA cards. Payment is required at the time of prescription pickup.
Multi-month supplies offer the best value for consistent LL-37 therapy. Prescriptions are valid for one year with physician approval.
LL-37 prescriptions are typically not covered by insurance plans. We provide detailed receipts for potential HSA/FSA reimbursement submissions.
Experience physician-prescribed LL-37 innate immune support therapy near you across Texas today. We serve eight communities with identical pharmaceutical quality standards.
Your innate immune system is your oldest and most immediate line of defense — and it depends on peptides like LL-37 to function at its best. InjectCo's eight Texas locations are booking LL-37 consultations now — spots fill quickly with patients who want to support their immune defense at the most fundamental biological level.
You deserve pharmaceutical-grade LL-37 prescribed by licensed medical professionals who understand innate immunity. Our 5-star ratings across every location prove we deliver consistent, trustworthy care. Your free consultation costs nothing but reveals everything about supporting your body's own frontline immune defense system. Book now and discover why immune-focused Texans choose InjectCo for LL-37 therapy.
These statements have not been evaluated by the Food and Drug Administration. LL-37 therapy is not intended to diagnose, treat, cure, or prevent any disease.
LL-37 therapy at InjectCo is prescribed by physicians as a compounded formulation for wellness support. This is not an FDA-approved drug product.
Individual results vary. Your response depends on multiple factors including baseline immune status, overall health, lifestyle, and individual physiology. We make no guarantees about specific outcomes.
Physician prescription required. All LL-37 therapy requires a physician consultation and prescription. Not all patients are candidates for LL-37 therapy.
Not a treatment for immune disease or skin disease. LL-37 is a wellness support peptide and is not prescribed to treat, manage, or cure any diagnosed immune disorder, skin condition, or infectious disease. Always consult your appropriate specialist about diagnosed conditions.
Not covered by insurance. LL-37 prescriptions for wellness support are typically self-pay. Check with your HSA/FSA administrator about potential reimbursement options.
For complete information about LL-37 therapy, potential side effects, and contraindications, please schedule a consultation with our medical team.
